MTTR 주가, 뉴스, 차트, 주식 조사, 프로필.

 (MTTR) 주식 시세 및 뉴스 요약

Matterport

Nasdaq sign

Equities

Sector ETFs

Broad U.S. Equity ETFs

Markets

Tech

ETFs

BKNG

DXCM

GILD

GOOG

GOOGL

ISRG

LULU

MTTR

ODFL

ORLY

QCOM

TEAM

나스닥 100 지수는 목요일 또 다른 하락세를 보이며 변동성이 심한 세션 이후 6월 초 이후 최저 수준으로 마감했다. 전날 나스닥 100 지수는 3.7% 하락해 2022년 10월 이후 최악의 하락세를 기록했다.

나스닥 100 지수는 거의 2년 만에 최악의 2일 하락폭을 기록하며  7주 만에 최저치

Stocks Photo by Jirapong Manustrong on Shutterstock

News

$BTC

RIOT

TSLA

미국 주식시장은 월요일 기관 투자가들의 활발한 거래로 인해 상승마감했다. 다우존스 산업평균지수는 0.7% 상승한 38,239.98에, S&amp;P 500 지수는 0.9% 상승한 5,010.60에 마감했으며, 나스닥 지수는 1.1% 상승한 15,451.31에 마감했다.
하루 동안 소매 투자자와 투자자들의 관심을 끈 최고의 주식들은 다음과 같다:
트럼프 미디어 &amp; 테크놀로지 그룹(NASDAQ:DJT)

월요일 주목받은 5개의 주식: 트럼프 미디어, 라이엇 플랫폼, 매터포트, 버라이즌, 테슬라

MATTERPORT INC COM CL A

Mattr Corp

Ceconomy AG

<a href="https://www.benzinga.com/topic/stephanie-link">Stephanie Link</a>, Chief Investment Strategist at Hightower Advisors, on Wednesday shared her insights on key stocks, emphasizing Amazon's growing dominance, Palo Alto Networks Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) cybersecurity potential, Target Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) recovery efforts and NextEra Energy Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) valuation opportunity.
What To Know: Link highlighted Amazon's <a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/02/43847764/amazon-tightens-grip-e-commerce-accelerates-jpmorgans-best-idea-2025">expanding market share</a>, which grew by 410 basis points last quarter, with improving profitability. She expects further acceleration in the latter half of the year despite capacity constraints.
Read Also: <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">Amazon Analyst Ratings</a>
On Palo Alto Networks, she sees a $15 billion annualized revenue opportunity in platformization and views it as a stronger long-term play compared to CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>), which she recently sold.
Target, down 24% since February, <a href="https://www.benzinga.com/personal-finance/25/03/44360075/retail-giant-target-which-relies-on-china-for-30-of-its-merchandise-warns-of-profit-hit-as-trumps-trade-war-bites">has struggled with product mix</a> but is showing signs of recovery, particularly in discretionary spending. Link says sustained improvement could restore investor confidence.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44403637/fed-holds-rates-while-growth-forecasts-slip-inflation-projections-rise">Fed Holds Rates While Growth Forecasts Slip, Inflation Projections Rise</a>
Meanwhile, she initiated a position in Nextera Energy, noting its historically high valuation but seeing an opportunity now that it trades at 18 times price-to-sales. She praised its joint venture with GE Vernova Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) in natural gas and data centers.
Additionally, Link named Boeing her top 2025 stock due to leadership changes and improving execution. She remains bullish on Palo Alto, Gap Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) turnaround under Richard Dixon, Target's resilience and Snowflake Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) AI-driven growth under new management.
Read now:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44399554/analysts-see-upside-for-95-of-sp-500-stocks-how-nvidia-tesla-stack-up" target="_blank" rel="noreferrer noopener">Analysts See Upside For 95% Of S&amp;P 500 Stocks: How Nvidia, Tesla Stack Up</a></li>
</ul>
Photo courtesy of Hightower Advisors

Trading Ideas

CRWD

PANW

SNOW

Stephanie Link: 'Amazon's Market Share is Soaring' – Insights On Amazon, Palo Alto Networks, Target & Nextera Energy

Management

NOV Promotes Jose Bayardo To President & COO And Rodney Reed To Senior Vice President & CFO

13 analysts have shared their evaluations of Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $98.62, a high estimate of $110.00, and a low estimate of $90.00. Witnessing a positive shift, the current average has risen by 5.28% from the previous average price target of $93.67.
<img src="https://www.benzinga.com/files/images/story/2025/1742418025_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Insmed. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Leonid Timashev</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Trung Huynh</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Leonid Timashev</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$100.00</td>
<td>-</td>
</tr>
<tr>
<td>Vamil Divan</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$101.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Announces</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Nicole Germino</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$108.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Stephen Willey</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$96.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Tiago Fauth</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$107.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Stephen Willey</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$97.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Jessica Fye</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Vamil Divan</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$101.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Matthew Harrison</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Insmed. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Insmed compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Insmed's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Insmed's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INSM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Insmed analyst ratings.</a>
<h2>Discovering Insmed: A Closer Look</h2>
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
<h3>Breaking Down Insmed's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Insmed's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 24.79%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Insmed's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -225.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Insmed's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -61.28%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Insmed's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -11.55%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Insmed's debt-to-equity ratio stands notably higher than the industry average, reaching 4.03. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

INSM

Expert Outlook: Insmed Through The Eyes Of 13 Analysts

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 40.39%. Currently, Parker Hannifin has a market capitalization of $81.12 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 5 years ago, it would be worth $6,457.67 today based on a price of $630.01 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742418011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Parker Hannifin 5 Years Ago Would Be Worth Today

<ul>
<li>Gross crypto revenues of $1.023 billion - $1.271 billion</li>
<li>Net loyalty revenues of $8.5 million - $9.9 million</li>
</ul>

Guidance

Bakkt Holdings, Inc. Class A Common Stock

BKKT

Bakkt Expects Q1 Total Revenues Of $1.03B - $1.28B

ProAssurance Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) shares are soaring in Wednesday&#8217;s after-hours session following the company announcement that it will be <a href="https://www.benzinga.com/pressreleases/25/03/b44405938/the-doctors-company-to-acquire-proassurance-corporation-for-25-00-per-share-in-cash">acquired by The Doctors Company</a>.
What Happened: After market close on Wednesday, ProAssurance announced it entered into a definitive agreement to be acquired by physician-owned medical malpractice insurer The Doctors Company for $25 per share in cash.
The deal has a transaction value of approximately $1.3 billion and represents a 60% premium to ProAssurance&#8217;s stock price at the close on Tuesday. 
&#8220;This transaction will deliver significant value to our shareholders,&#8221; said Ned Rand, president and CEO of ProAssurance.
&#8220;Bringing the strengths and capabilities of our companies together now will allow our teams to continue to serve today&#8217;s healthcare providers with the necessary scale and breadth of capabilities.&#8221;
Check This Out: <a href="https://www.benzinga.com/25/03/44405183/march-madness-2025-how-to-watch-betting-odds-and-the-one-stat-that-could-determine-a-winner">March Madness 2025: How To Watch, Betting Odds And The One Stat That Could Determine A Winner</a>
ProAssurance&#8217;s board unanimously approved the transaction. The deal is expected to close in the first half of 2026. Upon closing, ProAssurance&#8217;s common stock will no longer be listed on the New York Stock Exchange and the company will become a wholly-owned subsidiary of The Doctors Company.
&#8220;Healthcare is a team sport and the teams are getting larger. In order to provide them the best imaginable service requires a mission-based company with nationwide scale, resources and dedication to all medical professions and healthcare providers,&#8221; said Richard Anderson, chairman and CEO of The Doctors Company. 
PRA Price Action: <a href="http://benzinga.com/quote/pra">ProAssurance shares</a> were up 50.13% after-hours, trading at $23.33 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Health Care

After-Hours Center

Movers

ProAssurance Stock Jumps 50% On Takeover Deal With The Doctors Company

Bakkt Explores Strategic Alternatives, Including Potential Sale Or Wind-down, For Its Loyalty Business Segment

The divestiture is expected to streamline operations by reducing operating expenses by $3.8 million annually and freeing up approximately $3.0 million of capital held for regulatory reserves.

Asset Sales

BakktAgrees To Sell Qualified Custodian Subsidiary, Bakkt Trust Company, To ICE For Cash Of $1.5M Plus Assumption Of Regulatory Capital Requirement And Certain Costs

Earnings

X Financial Q4 Adj EPADS $1.16, Sales $234.1M

Epsilon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSN#NASDAQ">EPSN</a>) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.18 by 50 percent. This is a 70.97 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $31.523 million which missed the analyst consensus estimate of $31.610 million by 0.28 percent. This is a 2.58 percent increase over sales of $30.730 million the same period last year.

EPSN

Epsilon Energy FY 2024 GAAP EPS $0.09 Misses $0.18 Estimate, Sales $31.523M Miss $31.610M Estimate

Five Below Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) reported fourth-quarter financial results after the market close on Wednesday. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/03/g44405007/five-below-inc-announces-fourth-quarter-and-fiscal-2024-financial-results">from the retailer&#8217;s report</a>.
<ul>
<li>Q4 Revenue: $1.391 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $1.386 billion</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: $3.48, versus estimates of $3.38</li>
</ul>
Total revenue was up 4% year-over-year, while comparable sales decreased 3% year-over-year. The company reported operating income of $246.8 million in the fourth quarter. 
Five Below opened 22 new stores in the quarter, bringing total locations up to 1,771 at the quarter&#8217;s end. The company ended the period with $331.72 million in cash and cash equivalents.
&#8220;It has been a busy three months at Five Below. We are executing our key strategies around product, value and store experience, and doing so with a sharpened focus on our core customer — the kid and the kid in all of us,&#8221; said Winnie Park, CEO of Five Below.
Guidance: Five Below expects first-quarter revenue to be in the range of $905 million to $925 million versus estimates of $898.08 million. The company anticipates first-quarter adjusted earnings of 50 to 61 cents per share versus estimates of 49 cents per share. 
Five Below also provided guidance for the full year 2025. The company sees full-year revenue of $4.21 billion to $4.33 billion versus estimates of $4.27 billion. The company expects full-year adjusted earnings to be between $4.10 and $4.72 per share versus estimates of $5.06 per share.
The company&#8217;s guidance includes the expected impact of tariffs currently in place. Five Below executives will further discuss the quarter on a conference call with investors and analysts at 4:30 p.m. ET.
FIVE Price Action: <a href="http://benzinga.com/quote/five">Five Below shares</a> were up 8.61% after hours, trading at $82.10, at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44403637/fed-holds-rates-while-growth-forecasts-slip-inflation-projections-rise">Fed Holds Rates While Growth Forecasts Slip, Inflation Projections Rise</a></li>
</ul>
Photo: Shutterstock.

FIVE

Five Below Stock Moves Higher On Q4 Earnings Beat

Once this partnership takes effect, Bakkt believes it will be positioned to unlock new revenue streams in crypto trading and stablecoin payments, while adding efficiency to the vast and rapidly growing cross-border payments market.

Bakkt Enters Strategic Partnership With Distributed Technologies Research To Integrate Stablecoin-Based Payments Technology Infrastructure

"Heading into 2025, we expect consolidated top line growth in the mid-single digits and healthy activity levels across both segments as we begin to see the returns from our commercial initiatives targeting revenue growth in our higher margin call out and advanced service offerings and further expansion into adjacent markets such as midstream, aerospace, and general industrial lab inspection and testing . We see continued progress towards our Adjusted EBITDA margin target of at least 10% and expect at least 15% year over year growth in Adjusted EBITDA. Additionally, we recently expanded our initiatives to further optimize costs and improve workforce utilization, targeting annualized cost saving of at least $10 million. This entire management team remains committed to driving top line growth while continuously improving margins and cash flow generation. Finally, we plan to provide a more detailed investor update in the second quarter on our progress to date and our longer-term strategic vision for TEAM. I want to thank our dedicated and highly skilled employees who safely deliver best in class service every day, making it possible to continue building a financially stronger TEAM"

TISI

Team Inc Says Heading Into 2025, Expect Consolidated Top Line Growth In Mid-Single Digits

Bakkt Names Akshay Naheta To Serve As Co-CEO, Alongside Andy Main, Current CEO

Team Q4 EPS $(0.82) Up From $(3.18) YoY, Sales $213.30M Down From $214.13M YoY

Strategy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares traded higher on Wednesday along with other crypto-linked stocks in sympathy with overall market sentiment after the Federal Reserve decided to <a href="https://in.benzinga.com/economics/macro-economic-events/25/03/44403637/fed-holds-rates-while-growth-forecasts-slip-inflation-projections-rise">keep rates unchanged</a>.
What To Know: The Federal Reserve opted to keep the federal funds rate steady at 4.25%-4.50%, which is the same decision the Fed made back in January.
The statement released this afternoon highlighted that the economy is still growing at a healthy pace, the labor market remains strong, but inflation remains slightly high. Federal Reserve Chair Jerome Powell held a press conference following the decision.
During the conference, Powell acknowledged recession risks may have risen in recent months but stated an imminent downturn remains unlikely, according to <a href="https://www.cnn.com/business/live-news/federal-reserve-interest-rate-03-19-25/index.html">CNN</a>. This acknowledgment, along with the Fed&#8217;s decision to maintain rates, comes amid shifts in economic policies, including tariffs imposed by President Donald Trump.
The Fed&#8217;s decision may have reassured investors the economy is not facing an immediate threat, boosting overall market sentiment and benefiting the crypto space. Notably, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is trading at around $85,500, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Strategy is the largest corporate holder of Bitcoin, and as of March it has 466,226 of the crypto, according <a href="https://saylortracker.com/">to</a> The Crypto Times. Strategy has <a href="https://saylortracker.com/">spent</a> $33.1 billion on Bitcoin, with an average buying price of $66,380 per Bitcoin, the outlet added.
MSTR Price Action: Strategy shares closed Wednesday up 7.43% at $304.23, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Related Link: • <a href="https://www.benzinga.com/insights/short-sellers/25/03/44404019/how-do-investors-really-feel-about-avnet">How Do Investors Really Feel About Avnet?</a>
Photo: via Shutterstock

MSTR

What's Going On With Strategy Stock Wednesday?

Bakkt Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) reported quarterly losses of $(2.95) per share. This is a 59.31 percent increase over losses of $(7.25) per share from the same period last year. The company reported $1.80 billion in sales this quarter. This is a 737.76 percent increase over sales of $214.50 million the same period last year.

Bakkt Hldgs Q4 2024 GAAP EPS $(2.95) Down From $(0.29) YoY, Sales $1.797B Up From $214.50M YoY

Galecto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLTO#NASDAQ">GLTO</a>) reported quarterly losses of $(18.53) per share which missed the analyst consensus estimate of $(15.91) by 16.47 percent. This is a 48.64 percent increase over losses of $(36.08) per share from the same period last year.

GLTO

Galecto FY 2024 GAAP EPS $(18.53) Misses $(15.91) Estimate

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) has outperformed the market over the past 5 years by 6.13% on an annualized basis producing an average annual return of 24.59%. Currently, Reinsurance Gr has a market capitalization of $12.68 billion. 
Buying $100 In RGA: If an investor had bought $100 of RGA stock 5 years ago, it would be worth $335.24 today based on a price of $192.06 for RGA at the time of writing.
<h3>Reinsurance Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742417117_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Reinsurance Gr 5 Years Ago Would Be Worth Today

Google&#8217;s parent company, Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), is paying $32 billion to buy cloud cybersecurity startup Wiz —<a href="https://www.benzinga.com/tech/25/03/44376743/google-parent-alphabet-to-acquire-wiz-in-32-billion-deal-its-biggest-bet-yet"> a record deal for the company</a>. 
This is not a Google Cloud power play; it&#8217;s a deal that can upend the entire cybersecurity sector and provide a new spark to <a href="https://www.benzinga.com/etfs">ETFs invested in cloud computing</a>, cybersecurity, and mega-cap tech.
For those who want to surf the wave, three ETFs stand to gain: Amplify Cybersecurity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HACK#NYSE">HACK</a>), First Trust NASDAQ Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIBR#NASDAQ">CIBR</a>), and Global X Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUG#NASDAQ">BUG</a>).
<ul>
<li>Amplify Cybersecurity ETF: HACK follows the Nasdaq ISE Cyber Security Select Index and holds 25 stocks. Alphabet is not a core position, but M&amp;A rumors in the cybersecurity space could drive gains throughout the ETF. HACK has $2.01 billion in assets under management and levies 0.60% in annual fees. Interestingly, this was the first ever ETF dedicated solely to <a href="https://www.benzinga.com/topic/cybersecurity">the cybersecurity sector</a>.</li>
</ul>
<ul>
<li>First Trust NASDAQ Cybersecurity ETF: CIBR tracks the Nasdaq CTA Cybersecurity Index, with 32 holdings across the cybersecurity arena. With AUM of $8.03 billion, this ETF might experience increasing valuations and increasing deal speculation. It has a fee of 0.59% annually.</li>
</ul>
<ul>
<li>Global X Cybersecurity ETF: BUG invests in firms that will gain from the increasing demand for cybersecurity solutions. It follows the Indxx Cybersecurity Index, holding 28 stocks with a focus on network security, cloud protection, and cyber defense services. With $891.7 million in assets under management, BUG levies 0.50% in annual fees. With the rising significance of cloud security, this ETF may experience robust momentum as Alphabet&#8217;s Wiz acquisition puts more focus on the industry.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44144570/3-cybersecurity-etfs-in-focus-amid-reports-of-us-cyber-operations-suspension">3 Cybersecurity ETFs in Focus Amid Reports of US Cyber Operations Suspension</a>
<h2 class="wp-block-heading">Why Is Alphabet All-In On Wiz?</h2>
Wiz is no ordinary cybersecurity company. it&#8217;s among the fastest-growing cloud security brand names. Having been established in 2020, it enables companies to detect vulnerabilities in cloud environments, something that has become increasingly important with the growing need to combat rising cyber threats. With cyber attacks increasingly common and complex, companies are more concerned than ever before with cloud security.
For Alphabet, the transaction boosts Google Cloud&#8217;s standing against its heavyweight competitors—Amazon&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) AWS and Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure—both of which have been heavily investing in security products. 
The agreement also arrives at a time when cybersecurity M&amp;A is on the <a href="https://www.privateequityinternational.com/cybersecurity-sparks-back-to-life/">rise</a>. With the regulatory environment likely to be more accommodating with the current administration, this may be just the start of more large deals in the area.
Alphabet&#8217;s Wiz acquisition could be the tip of the iceberg for a new wave of cybersecurity M&amp;A. With threats in cyberspace growing by the day, cloud security remains a top priority for most companies. 
As cybersecurity emerges as a preeminent trend in tech investing, investors would be wise to watch HACK, CIBR, and BUG ETFs.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44400330/alphabets-wiz-acquisition-improves-competitive-positioning-but-there-are-concerns-analysts-say">Alphabet, Wiz Deal Represents Growth As Investors Appear &#8216;Twitchy&#8217;: Analysts</a></li>
</ul>
Image: Shutterstock

AMZN

CIBR

HACK

MSFT

Alphabet Bets Big On Cybersecurity: 3 ETFs Poised For A Jackpot

Press Releases

Matterport Announces Record Third Quarter 2024 Financial Results

General

Matterport Achieves AWS Manufacturing and Industrial Competency and Energy Competency

From Bullet Trains to Ancient Tombs: Matterport's Most Popular 3D Spaces of 2024

Matterport Chairman and CEO RJ Pittman Recognized as Inman Power Player for Third Consecutive Year

Matterport and CAPTUR3D Partner to Recognize Digital Twin Innovation Around the World

Matterport Recognized as a HousingWire 2025 Tech100 Real Estate Honoree for Innovation in Property Marketing Solutions

Introducing Matterport Marketing Cloud: The Ultimate Hub for Real Estate Agents to Get Listings to Market Faster

Matterport 2025 Winter Release: Productivity Multiplied Delivers The Next Leap in Property Marketing and Management

Matterport Announces Fourth Quarter 2024 Financial Results, with Over 50 Billion in Square Feet Under Management, up 33%, and Total Subscription Revenue up 14%, Year-over-Year

CoStar Group Completes Acquisition of Matterport, Ushering in a New Era of 3D Digital Twins and AI-Powered Real Estate Innovation

CSGP

Northland Capital Markets

Loop Capital

Piper Sandler

Wedbush

Morgan Stanley

Learn About Cryptocurrency

acf/sidebar-related-posts

Learn about this leading blockchain platform that supports decentralized applications and smart contracts.

What is Ethereum?

Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps.

How to Earn Interest on Ethereum

Discover the 10 best cryptocurrencies to invest in for January 2025. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!

10 Best Cryptocurrencies to Invest In for March 2025

10 Best Cryptocurrencies to Invest in for January 2025

Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin.

Top 10 Best Altcoins • Benzinga Crypto

10 Best Altcoins in November 2024

Top Cryptocurrency News

acf/news-feed

Future Finance Newsletter

acf/page-sidebar-placement

Cryptocurrency /Money Sidebar

개장가	-
종가	-
거래량 / 평균	- / -
일 범위	- - -
52주 범위	- - -
시가 총액	-
P/E 비율	-
배당 수익률	-
거래소
RSI	0
매도 수량	-
커버링 기간	1

개장가	-
종가	-
거래량 / 평균	- / -
일 범위	- - -
52주 범위	- - -
시가 총액	-
P/E 비율	-
배당 수익률	-
거래소
RSI	0
매도 수량	-
커버링 기간	1

Comments

예보

(MTTR) 주식 시세 및 뉴스 요약

최근 뉴스

재무

분석가 평가

비교

FAQ

뉴스

파트너 / 기고자

벤징가 글로벌

종목명

매출 변동
총 변동
EBITDA 변동
EBIT 변동
실적 변동